跳至主要内容
临床试验/CTRI/2021/07/034913
CTRI/2021/07/034913尚未招募2 期

A Randomized Open Label Clinical Trial To Evaluate The Efficacy OF SHADANGA GUGGULU Orally And KESHANJANA Local Application In The Management Of SHUSHKAKSHIPAKA With Special Reference To Meibomian Gland DysfunctionÂ

ational Institute of Ayurveda Jaipur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. 18 years and older patients of either sex.
  • 2. Patients presenting with signs and symptoms of
  • Shushkakshipaka.
  • 3. Patients presenting with signs of MGD â??
  • a. Ocular dryness.
  • b. Lid margin thickening or irregularity.
  • c. Meibomian gland orifice plugging.
  • d. Cloudy, yellow or frothy meibomian gland secretions.
  • e. Lid margin telangiectasia.
  • f. Meibomian gland capping.
  • 4. TBUT >5 seconds.
  • 5. Schirmerâ??test >10mm

排除标准

  • cases complicated with acute, chronic, infective conjunctivitis, any specific eyelid disorders, corneal ulcer, dacryocystitis and lagophthalmos
  • 2. inflammatory diseases unrelated to M.G.D
  • 3. Patient suffering from any systemic disorder or taking any medication which in the opinion of P.I. may affect the outcome of clinical trial
  • 4. contact lenes users
  • 5. history of ocular surgery within 6 months prior to enrollment in trial
  • 6. patient suffering from Steven Jhonson Syndrome and Sjogren Syndrome

研究者

发起方
ational Institute of Ayurveda Jaipur

相似试验